
Hederacolchiside C (CHEM114565)
| Record Information | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Version | 1.0 | ||||||||
| Creation Date | 2026-04-06 02:06:00 UTC | ||||||||
| Update Date | 2026-05-21 01:40:28 UTC | ||||||||
| Accession Number | CHEM114565 | ||||||||
| Identification | |||||||||
| Common Name | Hederacolchiside C | ||||||||
| Class | Small Molecule | ||||||||
| Description | Hederacolchiside C is a chemical compound with the molecular formula C59H96O25. Hederacolchiside C belongs to the terpene glycosides, a subclass of prenol lipids within the organic compounds. With an average molecular weight of 1,205 g/mol, Hederacolchiside C is a heavy molecule. This substance has been identified in or released from 13 recorded sources across several diverse sectors. Within the realm of electrical and electronic equipment, it is found in capacitors, batteries, cell phones, printed circuit boards, wires and cables, and one additional source. In the textiles, leather and furnishings sector, it is associated with carpets, rugs, and synthetic textiles. It is also present in food packaging within the food, food processing and cookware category. Additionally, Hederacolchiside C is found in medical devices from the healthcare, pharmaceuticals and veterinary products sector, as well as in lubricants used in energy, oil and gas and industrial manufacturing and chemical processing. One other sector has also been recorded. Recorded exposure routes for this compound include inhalation, oral intake, and touch. | ||||||||
| Contaminant Sources | Not Available | ||||||||
| Contaminant Type |
| ||||||||
| Chemical Structure | |||||||||
| Synonyms | Not Available | ||||||||
| Chemical Formula | C59H96O25 | ||||||||
| Average Molecular Mass | 1205.392 g/mol | ||||||||
| Monoisotopic Mass | 1204.624 g/mol | ||||||||
| CAS Registry Number | 36284-77-2 | ||||||||
| IUPAC Name | 6-Deoxy-alpha-L-mannopyranosyl-(1->3)-[alpha-D-glucopyranosyl-(1->2)]-1-O-[(3beta,5xi,18alpha)-3-{[2-O-(6-deoxy-alpha-L-mannopyranosyl)-alpha-L-arabinopyranosyl]oxy}-28-oxoolean-12-en-28-yl]-alpha-D-glucopyranose | ||||||||
| Traditional Name | Not Available | ||||||||
| SMILES | C[C@@H]1O[C@@H](O[C@@H]2[C@@H](O)[C@@H](O)CO[C@H]2O[C@H]2CC[C@@]3(C)C(CC[C@]4(C)[C@@H]3CC=C3[C@H]5CC(C)(C)CC[C@@]5(CC[C@@]43C)C(=O)O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)[C@H]3O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)C2(C)C)[C@H](O)[C@H](O)[C@H]1O | ||||||||
| InChI Identifier | InChI=1S/C59H96O25/c1-24-34(63)39(68)42(71)48(76-24)81-45-38(67)30(22-61)79-52(47(45)83-50-44(73)41(70)37(66)29(21-60)78-50)84-53(74)59-18-16-54(3,4)20-27(59)26-10-11-32-56(7)14-13-33(55(5,6)31(56)12-15-58(32,9)57(26,8)17-19-59)80-51-46(36(65)28(62)23-75-51)82-49-43(72)40(69)35(64)25(2)77-49/h10,24-25,27-52,60-73H,11-23H2,1-9H3/t24-,25-,27+,28-,29+,30+,31?,32+,33-,34-,35-,36-,37+,38+,39+,40+,41-,42+,43+,44+,45-,46+,47+,48-,49-,50+,51-,52+,56-,57+,58+,59-/m0/s1 | ||||||||
| InChI Key | BDYNJUHCBBNLKK-KXHZANHWSA-N | ||||||||
| Chemical Taxonomy | |||||||||
| Classification | Not classified | ||||||||
| Biological Properties | |||||||||
| Status | Detected and Not Quantified | ||||||||
| Origin | Not Available | ||||||||
| Cellular Locations | Not Available | ||||||||
| Biofluid Locations | Not Available | ||||||||
| Tissue Locations | Not Available | ||||||||
| Pathways | Not Available | ||||||||
| Applications | Not Available | ||||||||
| Biological Roles | Not Available | ||||||||
| Chemical Roles | Not Available | ||||||||
| Physical Properties | |||||||||
| State | Not Available | ||||||||
| Appearance | Not Available | ||||||||
| Experimental Properties |
| ||||||||
| Predicted Properties | Not Available | ||||||||
| Spectra | |||||||||
| Spectra |
| ||||||||
| Toxicity Profile | |||||||||
| Route of Exposure | Not Available | ||||||||
| Mechanism of Toxicity | Not Available | ||||||||
| Metabolism | Not Available | ||||||||
| Toxicity Values | Not Available | ||||||||
| Lethal Dose | Not Available | ||||||||
| Carcinogenicity (IARC Classification) | Not Available | ||||||||
| Uses/Sources | Not Available | ||||||||
| Minimum Risk Level | Not Available | ||||||||
| Health Effects | Not Available | ||||||||
| Symptoms | Not Available | ||||||||
| Treatment | Not Available | ||||||||
| Concentrations | |||||||||
| Not Available | |||||||||
| External Links | |||||||||
| Identifiers | Not Available | ||||||||
| References | |||||||||
| Synthesis Reference | Not Available | ||||||||
| MSDS | Not Available | ||||||||
| General References | Not Available | ||||||||